ID

25319

Description

Study Conclusion form Study ID: 208127/125 Clinical Study ID: 208127/125 (Ext-HAB-038 Month 90) Study Title: A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B

Keywords

Versions (3)
  1. 8/29/17 8/29/17 -
  2. 9/1/17 9/1/17 -
  3. 9/5/17 9/5/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

September 1, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Study Conclusion Biologicals HepA/HepB vaccine 208127/125

English

Study Conclusion Biologicals HepA/HepB vaccine 208127/125

1 forms  
Header
Description

Header

Alias
UMLS CUI-1
C1320722
Protocol
Description

Protocol

Data type

text

Alias
UMLS CUI [1]
C1507394
Subject number
Description

Subject number

Data type

text

Alias
UMLS CUI [1]
C2348585
Study Conclusion
Description

Study Conclusion

Has the code been broken ?
Description

Code broken

Data type

boolean

Alias
UMLS CUI [1]
C0805701
not applicable in case of an open study/a single-blind study
Description

Has the code been broken ? NA = not applicable

Data type

boolean

Alias
UMLS CUI [1]
C1272460
If yes, please comment :
Description

Code has been broken

Data type

text

Alias
UMLS CUI [1]
C0947611
Did the subject complete the study according to the protocol ? (excluding non-observance of the time intervals as these will be verified by SB later on)
Description

if No, mark the ONE most appropriate category and comment below

Data type

boolean

Alias
UMLS CUI [1]
C2348577
Adverse Experience (complete the Adverse Experience Section)
Description

Mark the ONE most appropriate category and comment below

Data type

boolean

Alias
UMLS CUI [1]
C0559546
Protocol violation
Description

Mark the ONE most appropriate category and comment below

Data type

boolean

Alias
UMLS CUI [1]
C1709750
Consent withdrawal by the subject
Description

Mark the ONE most appropriate category and comment below

Data type

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1511481
Lost to follow-up
Description

Mark the ONE most appropriate category and comment below

Data type

boolean

Alias
UMLS CUI [1]
C1302313
Termination by SmithKline Beecham
Description

Mark the ONE most appropriate category and comment below

Data type

boolean

Alias
UMLS CUI [1,1]
C2718058
UMLS CUI [1,2]
C0008961
Others, specify:
Description

Mark the ONE most appropriate category and comment below

Data type

text

Alias
UMLS CUI [1]
C3845569
Comments:
Description

Comments:

Data type

text

Alias
UMLS CUI [1]
C0947611
Date of last contact :
Description

day/month/year

Data type

date

Alias
UMLS CUI [1]
C0805839
Was the subject in good condition at date of last contact?
Description

if No, please give details within the Adverse Experience Section

Data type

boolean

Alias
UMLS CUI [1]
C2051434
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Date :
Description

day/month/year

Data type

date

Alias
UMLS CUI [1]
C0011008
Investigator Signature :
Description

I certify that I have reviewed the data in this case report form and that all information is complete and accurate.

Data type

text

Alias
UMLS CUI [1]
C2346576
Back to the top of the page

Similar models

Study Conclusion Biologicals HepA/HepB vaccine 208127/125

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Header
C1320722 (UMLS CUI-1)
Protocol
Item
Protocol
text
C1507394 (UMLS CUI [1])
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item Group
Study Conclusion
Code broken
Item
Has the code been broken ?
boolean
C0805701 (UMLS CUI [1])
not applicable
Item
not applicable in case of an open study/a single-blind study
boolean
C1272460 (UMLS CUI [1])
Please comment
Item
If yes, please comment :
text
C0947611 (UMLS CUI [1])
Study completed
Item
Did the subject complete the study according to the protocol ? (excluding non-observance of the time intervals as these will be verified by SB later on)
boolean
C2348577 (UMLS CUI [1])
Adverse Experience
Item
Adverse Experience (complete the Adverse Experience Section)
boolean
C0559546 (UMLS CUI [1])
Protocol violation
Item
Protocol violation
boolean
C1709750 (UMLS CUI [1])
Consent withdrawal
Item
Consent withdrawal by the subject
boolean
C2349954 (UMLS CUI [1,1])
C1511481 (UMLS CUI [1,2])
Lost to follow-up
Item
Lost to follow-up
boolean
C1302313 (UMLS CUI [1])
Termination by investigator
Item
Termination by SmithKline Beecham
boolean
C2718058 (UMLS CUI [1,1])
C0008961 (UMLS CUI [1,2])
Others, specify:
Item
Others, specify:
text
C3845569 (UMLS CUI [1])
Comments:
Item
Comments:
text
C0947611 (UMLS CUI [1])
Date of last contact
Item
Date of last contact :
date
C0805839 (UMLS CUI [1])
Good condition
Item
Was the subject in good condition at date of last contact?
boolean
C2051434 (UMLS CUI [1])
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Date
Item
Date :
date
C0011008 (UMLS CUI [1])
Signature
Item
Investigator Signature :
text
C2346576 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial